Johnson & Johnson: latest news, insights & analysis | Checkout Magazine

Johnson & Johnson To Buy Momenta In Billion Dollar Deal

Johnson & Johnson said on Wednesday it would buy Momenta Pharmaceuticals Inc for about $6.5 billion in cash to bolster its portfolio of treatments...

J&J Says It Could Produce 1bn Doses Of Potential COVID-19 Shot In 2021

Johnson & Johnson could produce 1 billion doses of its potential COVID-19 vaccine next year if it proves successful and would consider injecting he...

J&J Raises Forecast After Quarterly Profit Beats Estimates

Johnson & Johnson raised its full-year profit forecast and beat analysts' estimates for quarterly earnings on Thursday as strength in its pharmaceu...

Nonprofits Urge Johnson & Johnson To Halt Sales Of Baby Powder Globally

More than 170 nonprofit groups have called for Johnson & Johnson to stop selling its talc-based Johnson’s Baby Powder world-wide, citing conc...

Johnson & Johnson Drops Skin Whitening Creams

Johnson & Johnson has decided to stop selling skin whitening creams popular in Asia and the Middle East, it has said, after such products have...

Johnson & Johnson To Stop Selling Talc Baby Powder In U.S. And Canada

Johnson & Johnson on Tuesday announced it would stop selling its talc Baby Powder in the United States and Canada, saying demand had dropped in the...

J&J To Start Human Testing Of Coronavirus Vaccine By September

Johnson & Johnson plans to start human testing of its experimental coronavirus vaccine by September and make it ready for emergency use in early 20...